NEW YORK, July 14, 2015 /CNW/ -- E-QURE Corp. (OTCQB: EQUR), today announced that the July 9 presentation from Chairman Ron Weissberg, is now available for on-demand viewing at VirtualInvestorConferences.com.
E-QURE presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder materials from the "virtual trade booth" for the next three weeks.
Recent Company Highlights
- FDA PMA regulatory pathway has been chosen and is currently being conducted.
- European CE Mark is currently in renewal process.
- First distribution agreement was signed for Argentina market.
- Manufacturing capabilities are being reinstated for the BST device and the disposable electrodes.
Learn more about the event: http://VirtualInvestorConferences.com
E-QURE Corp. (OTCQB: EQUR) develops, manufactures and markets the E-QURE BST (Bioelectrical Signal Therapy) Device for the treatment and cure chronic wounds such as; pressure ulcers; diabetics foot ulcers; venous stasis ulcers and; hard to heal ulcers. The E-QURE BST device had few regulatory approvals in different part of the world that is currently being renewed. The company is seeking FDA approval for the device to start marketing it in the US. Please visit us at www.e-qure.com.
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PR Newswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Logo - http://photos.prnewswire.com/prnh/20150714/236155LOGO
SOURCE E-QURE Corp.
For further information: MEDIA - E-QURE Corp., Media relations, email@example.com; or VirtualInvestorConferences.com, Bradley H. Smith, Director of Marketing, IR and Compliance Services, PR Newswire, +1.201.947.7157, firstname.lastname@example.org, http://www.e-qure.com